Pharma Focus Asia
KP - Choose our fully recyclable blister films

Clearmind Medicine Collaborates with Johns Hopkins University for Clinical Research

Thursday, September 07, 2023

Clearmind Medicine has entered into a clinical trial agreement with Johns Hopkins University School of Medicine to conduct its Phase I/IIa clinical trial of its proprietary MEAI-based CMND-100, known as CM-CMND-001. 

This clinical trial is designed as a multinational, multi-centre study and aims to assess the tolerability, safety, and pharmacokinetics of CMND-100 in both healthy volunteers and individuals with alcohol use disorder (AUD).

This clinical trial represents an important step in exploring the potential of psychedelic drugs like CMND-100 to address neuropsychiatric conditions such as AUD and contribute valuable insights into their therapeutic use.

The primary objective of the CM-CMND-001 clinical trial is to determine the tolerable dosage of CMND-100 and to characterise its safety and pharmacokinetics/pharmacodynamics (PK/PD) in subjects receiving single and repeated doses.

Additionally, the secondary objective of the trial is to assess the effectiveness of CMND-100 in reducing drinking patterns and cravings among individuals with moderate-to-severe AUD. To achieve this, oral capsules of CMND-100 will be administered once daily for ten consecutive days. During the course of the clinical trial, patients will report their drinking patterns and cravings for alcohol, as well as their cravings for cigarettes if applicable.

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Is your drug program on trackMasterControl - Manufacturing demoMasterControl - QMS demoThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayThermo Fisher Scientific - PeptonesMerck - Mobius® products5th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023Pharma & Patient USA 2023Pharma Customer Engagement Europe 2023CHEMICAL INDONESIA 2024INALAB 2024